Complete response to sunitinib in a patient with relapsed irresectable renal cell carcinoma

被引：4
作者：
Angeles Vaz, Maria [1 ]
Pachon, Vanessa [1 ]
Grande, Enrique [1 ]
Ferreiro, Reyes [1 ]
Carrato, Alfredo [1 ]
机构：
[1] Ramon y Cajal Univ Hosp, Dept Med Oncol, Madrid, Spain
来源：
ANTI-CANCER DRUGS | 2011年 / 22卷 / 08期
关键词：
complete response; renal cell carcinoma; sunitinib; tyrosine kinase inhibitors; INTERFERON-ALPHA; SURVIVAL; THERAPY; CANCER; MANAGEMENT; RESECTION;
D O I：
10.1097/CAD.0b013e3283437ff9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We report a case with a complete pathology-proven remission after sunitinib treatment of a relapsed irresectable clear cell renal carcinoma. A significant objective response was observed with tumor size reduction during treatment. After surgery, on pathologic examination it was concluded that the patient exhibited a complete response; activity and the feasibility and safety of subsequent surgical resection were assessed. Otherwise after discontinuing sunitinib, the patient had a relapse on the same location; sunitinib has been resumed and was again found to be effective. Anti-Cancer Drugs 22:817-821 (C) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.
引用
收藏
页码：817 / 821
页数：5
相关论文
共 50 条
[21]   Sunitinib in Metastatic Renal Cell Carcinoma Patients With Brain Metastases [J].
Gore, Martin E. ;
Hariharan, Subramanian ;
Porta, Camillo ;
Bracarda, Sergio ;
Hawkins, Robert ;
Bjarnason, Georg A. ;
Oudard, Stephane ;
Lee, Se-Hoon ;
Carteni, Giacomo ;
Nieto, Alejandra ;
Yuan, Jinyu ;
Szczylik, Cezary .
CANCER, 2011, 117 (03) :501-509
[22]   Sunitinib for the treatment of metastatic renal cell carcinoma [J].
Oudard, Stephane ;
Beuselinck, Benoit ;
Decoene, Jasper ;
Albers, Peter .
CANCER TREATMENT REVIEWS, 2011, 37 (03) :178-184
[23]   Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients? [J].
Bozkurt, Oktay ;
Hacibekiroglu, Ilhan ;
Kaplan, Muhammet Ali ;
Duzkopru, Yakup ;
Uysal, Mukremin ;
Karaca, Halit ;
Berk, Veli ;
Inanc, Mevlude ;
Duran, Ayse Ocak ;
Ozaslan, Ersin ;
Ucar, Mahmut ;
Ozkan, Metin .
CLINICAL GENITOURINARY CANCER, 2015, 13 (06) :548-554
[24]   Sunitinib re-challenge in advanced renal-cell carcinoma [J].
Porta, C. ;
Paglino, C. ;
Gruenwald, V. .
BRITISH JOURNAL OF CANCER, 2014, 111 (06) :1047-1053
[25]   Long-term Safety of Sunitinib in Metastatic Renal Cell Carcinoma [J].
Porta, Camillo ;
Gore, Martin E. ;
Rini, Brian I. ;
Escudier, Bernard ;
Hariharan, Subramanian ;
Charles, Lorna P. ;
Yang, Liqiang ;
DeAnnuntis, Liza ;
Motzer, Robert J. .
EUROPEAN UROLOGY, 2016, 69 (02) :345-351
[26]   Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma Patients [J].
Zama, Ivan N. ;
Hutson, Thomas E. ;
Elson, Paul ;
Cleary, James M. ;
Choueiri, Toni K. ;
Heng, Daniel Y. C. ;
Ramaiya, Nikhil ;
Michaelson, M. Dror ;
Garcia, Jorge A. ;
Knox, Jennifer J. ;
Escudier, Bernard ;
Rini, Brian I. .
CANCER, 2010, 116 (23) :5400-5406
[27]   Treatment of Hemodialyzed Patients with Sunitinib in Renal Cell Carcinoma [J].
Park, Silvia ;
Lee, Jeeyun ;
Park, Se Hoon ;
Park, Joon Oh ;
Kang, Won Ki ;
Park, Young Suk ;
Cho, Jin Hyun ;
Lim, Ho Yeong .
CHEMOTHERAPY, 2010, 56 (06) :485-491
[28]   Safety and activity of sunitinib in elderly patients (≥70 years) with metastatic renal cell carcinoma: a multicenter study [J].
Brunello, A. ;
Basso, U. ;
Sacco, C. ;
Sava, T. ;
De Vivo, R. ;
Camerini, A. ;
Barile, C. ;
Roma, A. ;
Maruzzo, M. ;
Falci, C. ;
Zagonel, V. .
ANNALS OF ONCOLOGY, 2013, 24 (02) :336-342
[29]   Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma [J].
Billon, Emilien ;
Walz, Jochen ;
Brunelle, Serge ;
Thomassin, Jeanne ;
Salem, Naji ;
Guerin, Mathilde ;
Vicier, Cecile ;
Dermeche, Slimane ;
Albiges, Laurence ;
Tantot, Florence ;
Nenan, Soazig ;
Pignot, Geraldine ;
Gravis, Gwenaelle .
FRONTIERS IN ONCOLOGY, 2019, 9
[30]   Renal cell carcinoma: complete response [J].
Fernandez Calvo, Ovidio ;
Dopico Vazquez, Diana ;
Reboredo Lopez, Margarita ;
Anton Aparicio, Luis Miguel .
ANTI-CANCER DRUGS, 2010, 21 :S17-S18
12345